Soligenix’s HyBryte(TM) Treatment Now Within Reach for Rare Cancer Patients
HyBryte(TM) NDA Anticipated in H2 2022 New York, New York–(Newsfile Corp. – July 26, 2022)…
Month: July 2022
Older Homeowners Least Likely Cohort to Consider Tapping into Home Equity Despite Record Property Values, According to New Research from FAR
Inaugural “Home Equity Punch List” Survey Indicates Less Than Half of Baby Boomers Consider Home…
Ubicquia Launches UbiHub, the Easiest Way for Cities to Deploy Public Wi-Fi and Cameras for Traffic Analytics, Public Safety, and License Plate Recognition
Compatible with 360 million streetlights worldwide, industry’s first integrated Wi-Fi 6 and edge AI platform…
Predictive Analytics Global Markets Report 2022 Featuring Leading Players – Alphabet, Hewlett Packard, Microsoft, Oracle, SAP SE, Tableau Software, and Tibco Software – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Predictive Analytics: Global Markets” report has been added to ResearchAndMarkets.com’s offering. This report…
NovoDynamics Achieves HITRUST Certification for NovoHealth Dental
Risk-based, 2-year Certification Validates Company’s Commitment to Meeting Key Regulations and Protecting Sensitive Information ANN…
Top 10 Best Casinos To Visit In Las Vegas
The Sin City, or the epitome of entertainment or the center of world casinos. Las…
JumpCloud and CrowdStrike Partner to Deepen Device Security, Extend Security Coverage, and Achieve Compliance
JumpCloud’s full-disk encryption, cross-OS patching, and secure single sign-on now available through the CrowdStrike Store…
AXIM Biotechnologies Enhances IgE Testing Capabilities; Responds to Global Warming’s Impact on Allergy Season
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,”…
Biora Therapeutics to Participate in Upcoming BTIG Investment Conference
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Healthy Extracts Launches New Clinical Study Investigating UBN ACTIVATE™ Effect on Golfers’ Energy, Focus and Scores
Golf Performance Study Golfer undergoing V02 max profile to establish their basic aerobic fitness. ACTUAL…
SOTIO Doses First Patient in AURELIO-04 Phase 2 Trial of SOT101 in Combination with KEYTRUDA® (pembrolizumab)
AURELIO-04 will enroll up to 320 patients and test the combination in multiple solid tumor…
Revelation Biosciences Inc. Announces Pricing of $5 Million Public Offering
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) — Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company”…
TRACON Pharmaceuticals Announces Dosing of 36th Patient in ENVASARC Pivotal Trial Triggering Initial IDMC Efficacy Review Expected in the Fourth Quarter
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022
The Company Will Host a Conference Call and Webcast on August 10, 2022, at 8:30…
ORYZON Collaborates with the CMT Research Foundation in the US
To explore Oryzon’s HDAC6 inhibitors on Charcot-Marie-Tooth disease CMTRF to provide funding for in vivo…
COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022
LONDON, July 26, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH
MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH ZUG, Switzerland, July…
AGTC Receives Positive Type C Meeting Feedback from the FDA for the Company’s Design and Operating Procedures of its Planned cGMP Manufacturing Facility
— FDA feedback marks a key milestone in the construction of the facility expected to…
Aquestive Therapeutics to Participate in Wedbush PacGrow Healthcare Conference
WARREN, N.J., July 26, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
Rubius Therapeutics to Announce Second Quarter 2022 Financial Results
CAMBRIDGE, Mass., July 26, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…